StockNews.com assumed coverage on shares of bluebird bio (NASDAQ:BLUE – Free Report) in a research note published on Monday. The firm issued a sell rating on the biotechnology company’s stock.

BLUE stock opened at $4.95 on Friday. The company has a current ratio of 0.51, a quick ratio of 0.33 and a debt-to-equity ratio of 0.37. bluebird bio has a 12-month low of $3.56 and a 12-month ...

Lana Del Rey has shared a new single, “Bluebird.” The acoustic, country-inspired ballad was written by Del Rey and Luke Laird. They produced the single together with Drew Erickson.

I don't need to tell you that the '71 Datsun Bluebird 510 Wagon has a cult following ... as you might remember last year's release with blue stripes. The old Datsun Wagon made way for a newer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Golden confirmed his Chicago-based real estate firm, Blue Star Properties, is under contract to acquire the 26-story office building at 2 N. Riverside Plaza. Blue Star is poised to buy the 579,000 ...

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Blue Ridge Real Estate Company owns investment properties in Eastern Pennsylvania. The company operates through Resort Operations, Real Estate Management/Rental Operations, and Land Resource ...